Crispr Therapeutics shares owned by Granite Bay Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Granite Bay Wealth Management
from 13F filings
Historical chart of Granite Bay Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Granite Bay Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Granite Bay Wealth Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $1.2M | 20k | 57.70 |
2023-09-30 | $843k | 16k | 51.66 |
More positions owned by Granite Bay Wealth Management
View all positions for Granite Bay Wealth Management